ARCHIVES

In Brief: David Feigal To Head FDA’s Antiviral Division; ODAC To Discuss Melphalan, Amifostine NDAs

This article is from The Cancer Letter archive.

Vol. 18 No. 03 | January 17, 1992

Download PDF Visit The Full Archive

Related Articles

Upon, Panel Lean To Anecdotal Laetrile Study

August 12, 1977

In Brief: Byrd Heads ACS, Lee Clark President-Elect; NCI Needs Community Medical Oncologist

November 7, 1975

PhRMA Offers Assistance For Part D “Doughnut Hole”

June 26, 2009

Bone Marrow Transplant Survival Has Doubled In Young Patients

August 26, 2011

Cancer Program Critics Called “Irresponsible,” Demagogues”

March 21, 1975

RTOG Finds Twice A Day Radiation For Advanced Head And Neck Cancer Improved Local Tumor Control Rate

August 25, 2000